Home

Ausgezeichnet Koaleszenz Rand achim aigner leipzig Herzog Ziegenbock Land

Zeitschrift für Naturforschung C
Zeitschrift für Naturforschung C

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

Impact of medication on blood transcriptome reveals off-target regulations  of beta-blockers | PLOS ONE
Impact of medication on blood transcriptome reveals off-target regulations of beta-blockers | PLOS ONE

PEI-complexed LNA antiseeds as miRNA inhibitors
PEI-complexed LNA antiseeds as miRNA inhibitors

Influence of nanoparticle-mediated transfection on proliferation of primary  immune cells in vitro and in vivo | PLOS ONE
Influence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivo | PLOS ONE

Type of the Paper (Article
Type of the Paper (Article

Analysis of Transcriptional Regulation of the Human miR-17-92 Cluster;  Evidence for Involvement of Pim-1
Analysis of Transcriptional Regulation of the Human miR-17-92 Cluster; Evidence for Involvement of Pim-1

Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs

Programme – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Programme – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich

Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma

Evaluation of Colon-Specific Plasma Nanovesicles as New Markers of  Colorectal Cancer
Evaluation of Colon-Specific Plasma Nanovesicles as New Markers of Colorectal Cancer

Drug Delivery by Ultrasound-Responsive Nanocarriers for Cancer Treatment
Drug Delivery by Ultrasound-Responsive Nanocarriers for Cancer Treatment

Accommodation – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH  Zurich
Accommodation – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Front Cover: Balancing Histone Deacetylase (HDAC) Inhibition and  Drug‐likeness: Biological and Physicochemical Evaluation of Class I  Selective HDAC Inhibitors (ChemMedChem 9/2022) - Schäker‐Hübner - 2022 -  ChemMedChem - Wiley Online Library
Front Cover: Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors (ChemMedChem 9/2022) - Schäker‐Hübner - 2022 - ChemMedChem - Wiley Online Library

Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis  in prostate carcinoma and melanoma
Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Cell-type specific and non-redundant anti-proliferative effects of  shRNA-mediated Galpha12- and Galpha13 knockdown in lung canc
Cell-type specific and non-redundant anti-proliferative effects of shRNA-mediated Galpha12- and Galpha13 knockdown in lung canc

SATB1 as oncogenic driver and potential therapeutic target in head & neck  squamous cell carcinoma (HNSCC) | Scientific Reports
SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC) | Scientific Reports

Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in  colon carcinoma
Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in colon carcinoma